Paul M Cinciripini, PHD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paul M Cinciripini, PHD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:29 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT01182766 · New Treatment for Alcohol and Nicotine DependenceUniversity of Virginia · completed · Alcohol Dependence, Nicotine Dependence · principal investigator
- Ph3NCT00943618 · Combining Varenicline and Bupropion for Smoking CessationM.D. Anderson Cancer Center · completed · Smoking Cessation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- New Pharmacotherapy for Alcohol and Co-morbid DisordersR01AA019720 · NIAAA · UNIVERSITY OF VIRGINIA · PI NASSIMA AIT-DAOUD, ROBERT M ANTHENELLI, PAUL MICHAEL CINCIRIPINI, Bankole A Johnson · fiscal years 2010 to 2014Named on NCT01182766
- Effectiveness of Varenicline vs. Varenicline plus Bupropion for Smoking CessationR01DA024709 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PAUL MICHAEL CINCIRIPINI · fiscal years 2009 to 2014Named on NCT00943618
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.